The Future of Organ Procurement.

Area of Science:

• Nephrology and Transplantation Science
• Regenerative Medicine
• Immunology

Background:

• Organ procurement organizations strive for self-sufficiency to meet patient demand.
• Terminal renal failure affects a significant patient population requiring kidney replacement therapy.
• Current organ availability falls short of the demand for kidney transplantation.

Purpose of the Study:

• To outline a strategic approach for achieving organ donation self-sufficiency by 2023.
• To identify key areas for intervention to balance organ supply and demand.
• To project the impact of emerging medical technologies on kidney transplantation outcomes.

Main Methods:

• Review of current trends in renal failure progression and management.
• Analysis of the potential of SGLT2 inhibitors in delaying end-stage renal disease.
• Assessment of advancements in bioartificial kidney development and xenotransplantation research.

Main Results:

• SGLT2 inhibitors demonstrate efficacy in delaying the progression of renal failure, thereby reducing demand for kidneys.
• Bioartificial kidney technology and xenotransplantation present viable avenues for increasing organ availability.
• A combined strategy of demand reduction and supply increase can facilitate organ self-sufficiency.

Conclusions:

• Achieving organ self-sufficiency for kidney transplantation is a realistic goal by 2023.
• Pharmacological interventions like SGLT2 inhibitors are crucial for managing demand.
• Innovations in regenerative medicine and cross-species transplantation are vital for augmenting organ supply.